Article Details
Retrieved on: 2018-01-17 00:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Akebia Therapeutics Incorporated (NASDAQ:AKBA) had a decrease of 3.98% in short interest. AKBA's SI was 2.55 million shares in January as released by FINRA. Its down 3.98% from 2.65 million shares previously. With 379,500 avg volume, 7 days are for Akebia Therapeutics Incorporated ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here